Literature DB >> 15586606

Toxic epidermal necrolysis as a complication of treatment with voriconazole.

David B Huang1, Jashin J Wu, Christopher J Lahart.   

Abstract

An 81-year-old female received voriconazole in a 7-day treatment course for a symptomatic Candida krusei urinary tract infection. Four days after the last dose, she developed toxic epidermal necrolysis. She was treated with intravenous immunoglobulin, and her symptoms promptly resolved.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15586606     DOI: 10.1097/01.SMJ.0000144618.80128.F9

Source DB:  PubMed          Journal:  South Med J        ISSN: 0038-4348            Impact factor:   0.954


  3 in total

1.  SREBP-dependent triazole susceptibility in Aspergillus fumigatus is mediated through direct transcriptional regulation of erg11A (cyp51A).

Authors:  Sara J Blosser; Robert A Cramer
Journal:  Antimicrob Agents Chemother       Date:  2011-10-17       Impact factor: 5.191

Review 2.  Voriconazole : a review of its use in the management of invasive fungal infections.

Authors:  Lesley J Scott; Dene Simpson
Journal:  Drugs       Date:  2007       Impact factor: 9.546

3.  Management of dysphagia in toxic epidermal necrolysis (TEN) and Stevens-Johnson syndrome (SJS).

Authors:  Nicola A Clayton; Peter J Kennedy
Journal:  Dysphagia       Date:  2007-02-08       Impact factor: 3.438

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.